Clinical Trial Update: Autologous Platelet-Rich Plasma in the Management of Asherman Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating autologous platelet-rich plasma for intrauterine adhesion (Asherman syndrome) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrauterine Adhesion

Drugs mentioned

• Platelet-rich plasma (platelet-rich plasma)

Snippet

Sponsor: Ain Shams University | Conditions: Intrauterine Adhesion | Phase 2 | Status: COMPLETED